Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;11(1):12–26. doi: 10.1111/j.1750-3639.2001.tb00377.x

Galectins Are Differentially Expressed in Supratentorial Pilocytic Astrocytomas, Astrocytomas, Anaplastic Astrocytomas and Glioblastomas, and Significantly Modulate Tumor Astrocyte Migration

Isabelle Camby 1, Nathalie Belot 1, Sandrine Rorive 2, Florence Lefranc 3, Claude‐Alain Maurage 4, Harald Lahm 5, Herbert Kaltner 6, Yaron Hadari 7, Marie‐Magdeleine Ruchoux 4, Jacques Brotchi 3, Ehiel Zick 8, Isabelle Salmon 2, Hans‐Joachim Gabius 6, Robert Kiss 1,✉
PMCID: PMC8098336  PMID: 11145198

Abstract

Galectins, a family of mammalian lectins with specificity to β‐galactosides, are involved in growth‐regulatory mechanisms and cell adhesion. A relationship is assumed to exist between the levels of expression of galectins and the level of malignancy in human gliomas. A comparative study of this aspect in the same series of clinical samples is required to prove this hypothesis. Using computer‐assisted microscopy, we quantitatively characterized by immunohistochemistry the levels of expression of galectins‐1, ‐3 and‐8 in 116 human astrocytic tumors of grades I to IV. Extent of transcription of galectins‐1, ‐3, and ‐8 genes was investigated in 8 human glioblastoma cell lines by means of RT‐PCR techniques. Three of these cell lines were grafted into the brains of nude mice in order to characterize in vivo the galectins‐1, ‐3 and ‐8 expression in relation to the patterns of the tumor invasion of the brain. The role of galectin‐1, ‐3 and ‐8 in tumor astrocyte migration was quantitatively determined in vitro by means of computer‐assisted phase‐contrast videomicroscopy. The data indicate that the levels of galectin‐1 and galectin‐3 expression significantly change during the progression of malignancy in human astrocytic tumors, while that of galectin‐8 remains unchanged. These three galectins are involved in tumor astrocyte invasion of the brain parenchyma since their levels of expression are higher in the invasive parts of xenografted glioblastomas than in their less invasive parts. Galectin‐3, galectin‐1, and to a lesser extent galectin‐8, markedly stimulate glioblastoma cell migration in vitro. Since bands for the transcripts of human galectins‐2, ‐4 and ‐9 were apparently less frequent and intense in the 8 human glioblastoma cell lines, this system provides an excellent model to assign defined roles to individual galectins and delineate overlapping and distinct functional aspects.

Full Text

The Full Text of this article is available as a PDF (616.1 KB).

References

  • 1. Agrwal N, Sun Q, Wang SY, Wang JL (1993). Carbohydrate‐binding protein 35. Properties of the recombinant polypeptide and the individuality of the domains. J Biol Chem 268: 14932–14939. [PubMed] [Google Scholar]
  • 2. Bardosi A, Dimitri T, Gabius HJ (1988). Endogenous carbohydrate‐binding proteins in oligodendrogliomas. A histochemical study. Acta Neuropathol 76: 55–61. [DOI] [PubMed] [Google Scholar]
  • 3. Bardosi A, Dimitri T, Wosgien B, Gabius HJ (1989). Expression of endogenous receptors of neoglycoproteins, especially lectins, that allow fiber typing on formaldehyde‐fixed, paraffin‐embedded muscle biopsy specimens. A glycohistochemical, immunohistochemical, and glycobiochemical study. J Histochem Cytochem 37: 989–998. [DOI] [PubMed] [Google Scholar]
  • 4. Bigner SH, Schrock E (1998). Molecular cytogenetics of brain tumors. J Neuropathol Exp Neurol 56: 1173–1181. [DOI] [PubMed] [Google Scholar]
  • 5. Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A (1997). Expression of the endogenous galactose‐binding protein galectin‐3 correlates with the malignant potential of tumours in the central nervous system. Cancer 80: 776–787. [PubMed] [Google Scholar]
  • 6. Brochauser I, Schutzbach J, Kuhns W (1998). Glycoproteins and their relationship to human disease. Acta Anat 161: 36–78. [DOI] [PubMed] [Google Scholar]
  • 7. Burg MA, Nishiyama A, Stallcup WB (1997). A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Exp Cell Res 235: 254–264. [DOI] [PubMed] [Google Scholar]
  • 8. Camby I, Decaestecker C, Gordower L, DeDecker R, Kacem Y, Lemmers A, Siebert HC, Bovin NV, Wesseling P, Danguy A, Salmon I, Gabius HJ, Kiss R (2000). Distinct differences in binding capacity to saccharide epitopes in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas. J Neuropathol Exp Neurol, In Press. [DOI] [PubMed] [Google Scholar]
  • 9. Camby I, Nagy N, Lopes MB, Schafer BW, Maurage CA, Ruchoux MM, Murmann P, Pochet R, Heizmann CW, Brotchi J, Salmon I, Kiss R, Decaestecker C (1999). Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol 9: 825–843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Camby I, Salmon I, Danguy A, Pasteels JL, Brotchi J, Martinez J, Kiss R (1996). Influence of gastrin on human astrocytic tumor cell proliferation. J Natl Cancer Inst 88: 594–600. [DOI] [PubMed] [Google Scholar]
  • 11. Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM (1989). Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 58: 945–953. [DOI] [PubMed] [Google Scholar]
  • 12. Decaestecker C, Camby I, Gordower L, DeWitte O, Cras P, Martin JJ, Pasteels JL, Van Ham Ph, Brotchi J, Kiss R, Salmon I (1998). Characterization of the astroglial versus the oligodendroglial origin of glioblastomas by means of quantitative morphonuclear variables generated by computed‐assisted microscopy. J Neuropathol Exp Neurol 57: 791–802. [DOI] [PubMed] [Google Scholar]
  • 13. Decaestecker C, Camby I, Nagy N, Brotchi J, Kiss R, Salmon I (1998). Improving morphology‐based malignancy grading schemes in astrocytic tumors by means of computer‐assisted techniques. Brain Pathol 8: 29–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Decaestecker C, Lopes MB, Gordower L, Camby I, Cras P, Martin JJ, Kiss R, VandenBerg S, Salmon I (1997). Quantitative chromatin pattern description in Feulgenstained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligoastrocytomas. J Neuropathol Exp Neurol 56: 391–402. [DOI] [PubMed] [Google Scholar]
  • 15. Decaestecker C, Salmon I, Camby I, DeWitte O, Pasteels JL, Brotchi J, Van Ham Ph, Kiss R (1995). Identification of high versus lower risk clinical subgroups in a group of adult patients with supratentorial anaplastic astrocytomas. J Neuropathol Exp Neurol 54: 371–384. [DOI] [PubMed] [Google Scholar]
  • 16. Decaestecker C, Salmon I, DeWitte O, Camby I, Van Ham Ph, Pasteels JL, Brotchi J, Kiss R (1997). Nearest‐neighbour classification for the identification of aggressive versus non‐aggressive low‐grade astrocytic tumors by means of image‐cytometry‐generated variables. J Neurosurg 86: 532–537. [DOI] [PubMed] [Google Scholar]
  • 17. De Hauwer C, Camby I, Darro F, Decaestecker C, Gras T, Salmon I, Kiss R, Van Ham P (1997). Dynamic characterization of glioblastoma cell motility. Biochem Biophys Res Commun 232: 267–272. [DOI] [PubMed] [Google Scholar]
  • 18. De Hauwer C, Camby I, Darro F, Migeotte I, Decaestecker C, Verbeek C, Danguy A, Pasteels JL, Brotchi J, Salmon I, Van Ham P, Kiss R (1998). Gastrin inhibits motility, decreases cell death and increases cell proliferation in human glioblastoma cell lines. J Neurobiol 37: 373–382. [DOI] [PubMed] [Google Scholar]
  • 19. Enam AS, Rosenblum ML, Edvardsen K (1998). Role of extracellular matrix in tumor invasion: Migration of glioma cells along fibronectin‐positive mesenchymal cell processes. Neurosurgery 42: 599–608. [DOI] [PubMed] [Google Scholar]
  • 20. Francois C, Van Velthoven R, De Lathouwer O, Moreno C, Peltier A, Kaltner H, Salmon I, Gabius HJ, Danguy A, Decaestecker C, Kiss R (1999). Galectin‐1 and galectin‐3 binding pattern expression in renal cell carcinomas. Am J Clin Pathol 112:194–203. [DOI] [PubMed] [Google Scholar]
  • 21. Gabius HJ (1990). Influence of type of linkage and spacer on the interaction of b‐galactoside‐binding proteins with immobilized affinity ligands. Anal Biochem 189: 91–94. [DOI] [PubMed] [Google Scholar]
  • 22. Gabius HJ (1997). Animal lectins. Eur J Biochem 243: 543–576. [DOI] [PubMed] [Google Scholar]
  • 23. Gabius HJ (2000). Glycohistochemistry: the why and how of detection and localisation of endogenous lectins. Anat Embryol Histol, In Press. [DOI] [PubMed] [Google Scholar]
  • 24. Gabius HJ (2000). Biological information transfer beyond the genetic code: the sugar code. Naturwissenschaften 87:108–121. [DOI] [PubMed] [Google Scholar]
  • 25. Gabius HJ, Engelhardt R, Rehm S, Barondes SH, Cramer F (1986). Presence and relative distribution of three endogenous β‐galactoside‐specific lectins in different tumor types of rat. Cancer J 1: 19–22. [Google Scholar]
  • 26. Giannini G, Scheithauer BW (1997). Classification and grading of low‐grade astrocytic tumors in children. Brain Pathol 7: 785–798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Giese A, Kluwe L, Laube B, Meissner H, Berens ME, Westphal M (1996). Migration of human glioma cells on myelin. Neurosurgery 38: 755–764. [PubMed] [Google Scholar]
  • 28. Giese A, Loo MA, Norman SA, Treasurywala S, Berens ME (1996). Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. J Cell Sci 109: 2161–2168. [DOI] [PubMed] [Google Scholar]
  • 29. Giese A, Rief MD, Loo MA, Berens ME (1994). Determinants of human astrocytoma migration. Cancer Res 54: 3897–3904. [PubMed] [Google Scholar]
  • 30. Gladson CL (1999). The extracellular matrix of gliomas: modulation of cell function. J Neuropathol Exp Neurol 58: 1029–1040. [DOI] [PubMed] [Google Scholar]
  • 31. Gordower L, Decaestecker C, Kacem Y, Lemmers A, Gusman J, Burchert M, Danguy A, Gabius HJ, Salmon I, Kiss R, Camby I (1999). Galectin‐3 and galectin‐3‐binding‐site expression in human adult astrocytic tumors and related angiogenesis. Neuropathol Appl Neurobiol 25: 319–330. [DOI] [PubMed] [Google Scholar]
  • 32. Hadari YR, Arbel‐Goren R, Levy Y, Amsterdam A, Alon R, Zakut R, Zick Y (2000). Galectin‐8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 113:2385–2387. [DOI] [PubMed] [Google Scholar]
  • 33. Hadari YR, Paz K, Dekel R, Mestrovic T, Accili D, Zick Y (1995). Galectin‐8. A new rat lectin, related to galectin‐4. J Biol Chem 270: 3447–3453. [DOI] [PubMed] [Google Scholar]
  • 34. Hirabayashi J (ed) (1997). Recent topics on galectins. Trends Glycosci Glycotechnol 9: 1–180. [Google Scholar]
  • 35. Ho DM, Wong TT, Hsu CY, Ting LT, Chiang H (1998). MIB‐1 labeling index in nonpilocytic astrocytomas of childhood: a study of 101 cases. Cancer 82: 2459–2466. [DOI] [PubMed] [Google Scholar]
  • 36. Joubert R, Kuchler S, Zanetta JP, Bladier D, Avellana‐Adalid V, Caron M, Doinel C, Vincendon G (1989). Immunohistochemical localization of β‐galactoside‐binding lectin in rat central nervous system. 1. Light‐ and electron‐microscopical studies on developing cerebral cortex and corpus callosum. Dev Neurosci 11: 397–413. [DOI] [PubMed] [Google Scholar]
  • 37. Key B, Puche AC (1997). Role of galectin‐1 in the olfactory nervous system. Trends Glycosci Glycotechnol 7: 41–45. [Google Scholar]
  • 38. Kiss R, Camby I, Salmon I, Van Ham Ph, Brotchi J, Pasteels JL (1995). Relationship between DNA ploidy level and tumor sociology behavior in 12 nervous cell lines. Cytometry 20: 118–126. [DOI] [PubMed] [Google Scholar]
  • 39. Kleihues P, Burger PC, Scheithauer BW, eds. (1993). Histological typing of tumours of the central nervous system, World Health Organisation International Histological Classification of Tumours, 2nd Edition, Springer Verlag: Berlin . [Google Scholar]
  • 40. Kruczynski A, Salmon I, Camby I, Limouzy A, Rombaut K, Pasteels JL, Delsol G, Brotchi J, Kiss R (1995). The characterization of nuclear DNA content, the proliferative activity and the immunohistochemical expression of GFAP, VIM, LEU7, S‐100, p53 and cathepsin D in primitive human glioblastoma multiformes (hGBMs) versus human GBM cell lines grafted into the brains of nude mice. Int J Oncol 6: 473–481. [DOI] [PubMed] [Google Scholar]
  • 41. Kuklinski S, Pesheva P, Heimann C, Urschel S, Gloor S, Graeber S, Herzog V, Pietsch T, Wiestler OD, Probstmeier R (2000). Expression pattern of galectin‐3 in neural tumor cell lines. J Neurosci Res 60: 45–57. [DOI] [PubMed] [Google Scholar]
  • 42. Lahm H, Amstad P, Yilmaz Z, Borbenyi Z, Wyniger J, Fischer JR, Suardet L, Givel JC, Odartchenko N (1995). Interleukin‐4 down‐regulates expression of c‐kit and autocrine stem cell factor in human colorectal carcinoma cells. Cell Growth Differ 6:1111–1118. [PubMed] [Google Scholar]
  • 43. Lahm H, Hoeflich A, Andre S, Sordat B, Kaltner H, Wolf B, Gabius HJ (2000). Gene expression of galectin‐9/ecalectin, a potent eosinophil chemoattractant, and/or the insertional isoform in human colorectal carcinoma cell lines and detection of frameshift mutations for protein sequence truncations in the second functional lectin domain. Int J Oncol, In Press. [DOI] [PubMed] [Google Scholar]
  • 44. Louis D (1997). A molecular genetic model for astrocytoma histopathology. Brain Pathol 7: 755–764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Reuter G, Gabius HJ (1999). Eukaryotic glycosylation: whim of nature or multipurpose tool Cell Mol Life Sci 55: 368–422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Rutka JT, Apodaca G, Stern R, Rosenblum M (1988). The extracellular matrix of the central and peripheral nervous systems: Structure and function. J Neurosurg 69: 155–170. [DOI] [PubMed] [Google Scholar]
  • 47. Sasaki H, Yoshida K, Ikeda E, Asou H, Inaba M, Otani M, Kawase T (1998). Expression of the neural cell adhesion molecule in astrocytic tumors. An inverse correlation with malignancy. Cancer 82: 1921–1931. [DOI] [PubMed] [Google Scholar]
  • 48. Schwarz G Jr, Remmelink M, Decaestecker C, Gielen I, Budel V, Burchert M, Darro F, Danguy A, Gabius HJ, Salmon I, Kiss R 1999). Galectin fingerprinting in tumor diagnosis. Differential expression of galectin‐3 and galectin‐3 binding sites, but not galectin‐1, in benign vs malignant uterine smooth muscle tumors. Am J Clin Pathol 111: 623–631. [DOI] [PubMed] [Google Scholar]
  • 49. Siebert HC, Adar R, Arango R, Burchert M, Kaltner H, Kayser G, Tajkhorshid E, von der Lieth CW, Kaptein R, Sharon N, Vliegenthart JF, Gabius HJ (1997). Involvement of laser photo CIDNP (chemically induced dynamic nuclear polarization)‐reactive amino‐acid side chains in ligand binding by galactoside‐specific lectins in solution. Eur J Biochem 249: 27–38. [DOI] [PubMed] [Google Scholar]
  • 50. John JA St, Key B (1999). Expression of galectin‐1 in the olfactory nerve pathway of rat. Brain Res Dev Brain Res 117:171–178. [DOI] [PubMed] [Google Scholar]
  • 51. Stroeken PJ, van Rijthoven EA, van der Valk MA, Roos E (1998). Targeted disruption of the beta1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity. Cancer Res 58: 1569–1577. [PubMed] [Google Scholar]
  • 52. Yamaoka K, Mishima K, Nagashima Y, Asai A, Sanai Y, Kirino T (2000). Expression of galectin‐1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin‐1 inhibits the growth of 9 glioma cells. J Neurosci Res 59: 722–730. [DOI] [PubMed] [Google Scholar]
  • 53. Yates AJ, Comas T, Scheithauer BW, Burger PC, Pearl DK (1999). Glycolipid markers of astrocytomas and oligoden‐drogliomas. J Neuropathol Exp Neurol 58:1250–1262. [DOI] [PubMed] [Google Scholar]
  • 54. Zanetta JP (1998). Structure and functions of lectins in the central and peripheral nervous system. Acta Anat 161: 180–195. [DOI] [PubMed] [Google Scholar]
  • 55. Zhang H, Kelly G, Zerillo C, Jaworski DM, Hockfield S (1998). Expression of a cleaved brain‐specific extracellular matrix protein mediates glioma cell invasion in vivo. J Neurosci 18: 2370–2376. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES